Clinical Trials Browser

NIH × Sarcoma × Vorinostat × Clear all

NCT01132911 2017-07-02

A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and Lymphomas

Phase 1 Completed

CNSGenitourinaryLymphoidSarcoma

Lymphoma, Neoplasms, Wilms Tumor, Neuroblastoma, Sarcoma

NCT00937495 2014-05-14

Vorinostat and Bortezomib in Treating Patients With Advanced Soft Tissue Sarcoma

Phase 2 Completed

16 enrolled 6 charts

Sarcoma